Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Study of Cell-mediated Response in Mice by HPV16 L1 Virus-like Particles Expressed in Saccharomyces cerevisiae

  • Published : 2007.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

The first vaccine against human papillomaviruses (HPV) formulated with HPV16 L1 virus-like particles (VLPs) produced in yeast was approved by the FDA in June 2006. Nevertheless, there have been few studies of the immunogenicity in mice of VLPs. In this study, we evaluated the cell-mediated immune response to VLPs produced in Saccharomyces cerevisiae. After immunization of mice with HPV16 L1 VLPs, we measured splenocytes proliferation and the levels of IFN$_{\gamma}$, IL2, IL4, and IL5. Splenocytes proliferation was significantly increased and a mixed Th1/Th2 response was indicated. IgG subtype immunoresponses were strongly induced and IgG1 titers were higher than those of IgG2a.

Keywords

References

  1. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87: 796-802 https://doi.org/10.1093/jnci/87.11.796
  2. Dupuy, C., D. Buzoni-Gatel, A. Touze, P. Le Cann, D. Bout, and P. Coursaget. 1997. Cell-mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microb. Pathog. 22: 219-225 https://doi.org/10.1006/mpat.1996.0113
  3. Emeny, R. T., C. M. Wheeler, K. U. Jansen, W. C. Hunt, T. M. Fu, J. F. Smith, S. MacMullen, M. T. Esser, and X. Paliard. 2002. Priming of human papillomavirus type 11- specific humoral and cellular immune responses in collegeaged women with a virus-like particle vaccine. J. Virol. 76: 7832-7842 https://doi.org/10.1128/JVI.76.15.7832-7842.2002
  4. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303-333 https://doi.org/10.1146/annurev.iy.08.040190.001511
  5. Ha, C. H., K. H. Lim, S. H. Jang, C. W. Yun, H. D. Paik, S. W. Kim, C. W. Kang, and H. I. Chang. 2006. Immuneenhancing alkali-soluble glucans produced by wild-type and mutant Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 16: 576-583
  6. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67: 315-322
  7. Inglis, S., A. Shaw, and S. Koenig. 2006. Chapter 11: HPV vaccines: Commercial research and development. Vaccine 24Suppl3: S99-S105 https://doi.org/10.1016/j.vaccine.2006.05.119
  8. Khajuri, A., A. Gupta, F. Malik, S. Singh, J. Singh, B. D. Gupta, K. A. Suri, P. Suden, V. K. Srinivas, K. Ella, and G. N. Qazi. 2007. A new vaccine adjuvant (BOS 2000), a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine 25: 4586-4594 https://doi.org/10.1016/j.vaccine.2007.03.051
  9. Kim, E., H. Y. Poo, M. H. Sung, and C. J. Kim. 2005. Mature HIV-like particles produced from single Semliki Forest virus-derived expression vector. J. Microbiol. Biotechnol. 15: 1229-1239
  10. Kim, H. C., H. J. Kim, W. B. Choi, and S. W. Nam. 2006. Inulooligosaccharide production from inulin by Saccharomyces cerevisiae strain displaying cell-surface endoinulinase. J. Microbiol. Biotechnol. 16: 360-367
  11. Kim, H. Y., J. O. Yang, and G. E. Ji. 2005. Effect of bifidobacteria on production of allergy-related cytokines from mouse spleen cells. J. Microbiol. Biotechnol. 15: 265-268
  12. Kim, S. N., H. S. Jeong, S. N. Park, and H. J. Kim. 2007. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae. J. Virol. Methods 139: 24-30 https://doi.org/10.1016/j.jviromet.2006.09.004
  13. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein selfassembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89: 12180-12184
  14. Lee, J. S., J. Yu, H. J. Shin, Y. S. Kim, J. K. Ahn, C. K. Lee, H. Y. Poo, and C. J. Kim. 2005. Expression of hepatitis C virus structural protein in Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 15: 767-771
  15. Lowe, R. S., D. R. Brown, J. T. Bryan, J. C. Cook, H. A. George, K. J. Hofmann, W. M. Hurni, J. G. Joyce, E. D. Lehman, H. Z. Markus, M. P. Neeper, L. D. Schultz, A. R. Shaw, and K. U. Jansen. 1997. Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast. J. Infect. Dis. 176: 1141-1145 https://doi.org/10.1086/514105
  16. Marais, D., J. A. Passmore, J. Maclean, R. Rose, and A. L. Williamson. 1999. A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV viruslike particles. J. Gen. Virol. 80: 2471-2475 https://doi.org/10.1099/0022-1317-80-9-2471
  17. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J. Immunol. Methods 65: 55-63 https://doi.org/10.1016/0022-1759(83)90303-4
  18. Palker, T. J., J. M. Monteiro, M. M. Martin, C. Kakareka, J. F. Smith, J. C. Cook, J. G. Joyce, and K. U. Jansen. 2001. Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus viruslike particles. Vaccine 19: 3733-3743 https://doi.org/10.1016/S0264-410X(01)00093-7
  19. Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Estimates of worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80: 827-841 https://doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
  20. Pisani, P., D. M. Parkin, F. Bray, and J. Ferlay. 1999. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83: 18-29
  21. Rose, R. C., W. Bonnez, R. C. Reichman, and R. L. Garcea. 1993. Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of viruslike particles. J. Virol. 67: 1936-1944
  22. Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206: 126-135 https://doi.org/10.1016/S0042-6822(95)80027-1
  23. Volpers, C., P. Schirmacher, R. E. Streeck, and M. Sapp. 1994. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200: 504-512 https://doi.org/10.1006/viro.1994.1213
  24. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189: 12-19 https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F